Robert Nelsen, Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 36,430 shares at $50.56 ($1.8M) on 2017-02-21, disclosed to the SEC on 2017-02-23.
Open-market sale of $1.8M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.56 | 34,650 | $1.8M | 94.8% |
| 2 | $54.17 | 1,780 | $96K | 5.2% |
| Total | $50.74 avg | 36,430 | $1.8M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |